Brentuximab Vedotin Biosimilar - Research Grade
Product Specifications
Background
Brentuximab vedotin is an ADC consisting of a CD30-directed antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma.
Product Name Alternative
MMAE
Host
CHO Cells
Reactivity
Human
Target
TNFRSF8 / CD30
Isotype
IgG1
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR218166L3V 200 µL
Olfr494 (NM_146737) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details MBS7264706-01 48 Well
Chicken Endoplasmic Reticulum Aminopeptidase 1 ELISA Kit
Sign In for Pricing
View Details MBS7264706-02 96 Well
Chicken Endoplasmic Reticulum Aminopeptidase 1 ELISA Kit
Sign In for Pricing
View Details